Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Gastroenterology | Immunology | Family Medicine
Clinical Trials: Ulcerative Colitis
A listing of clinical trials currently looking for volunteers to enroll in Ulcerative Colitis studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : University of Alabama at Birmingham
An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease
Birmingham : University of Alabama at Birmingham
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Birmingham : Apex Clinical Trials
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Dothan : Digestive Health Specialists of the Southeast
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Mobile : Horizon Research Group, Inc.
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Mobile : Internal Medicine Center, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Mobile : Springhill Memorial Hospital
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Mobile : Santarus Clinical Investigational Site 1055
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Mobile :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Arizona
Phoenix :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Sun City : Investigational Site Number 840065
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Tucson : Adobe Clinical Research, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Tucson : Adobe Surgery Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Arkansas
Little Rock : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Little Rock : Arkansas Children's Hospital
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
California
Los Angeles : Gastrointestinal Bioscience
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Los Angeles : Cedars-Sinai Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Montebello : Paramount Medical Specialty
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Sacramento : Capital Gastroenterology Consultants Medical Group
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
San Diego : Research Site
Clinical Research Trial- Ulcerative Proctitis- Volunteers Needed
San Diego : Research Site
Clinical Research Trial- Ulcerative Proctitis- Volunteers Needed
San Diego : Clinical Applications Laboratories Inc.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
San Diego : Desta Digestive Disease Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Anaheim : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Anaheim : Santarus Clinical Investigational Site 1043
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Anaheim : Advanced Clinical Research Institute
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Francisco :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Glendale : Research Site
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Glendale : Research Site
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
La Jolla : UCSD Medical Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Lakewood : Santarus Clinical Investigational Site 1071
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Los Angeles : Cedars Sinai Medical Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Los Angeles : Cedars-Sinai Medical Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Los Angeles : Investigational Site Number 840031
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Los Angeles : Santarus Clinical Investigational Site 1051
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Los Angeles :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Mission Hills : Investigational Site Number 840059
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Oakland :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Palm Springs : Homan A Zadeh, MD, MPH
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
San Diego : Sharp Rees-Stealy Medical Group
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
San Diego : Clinical Application Laboratories, Inc.
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
San Diego : San Diego Endoscopy Center
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
San Diego : Investigational Site Number 840074
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
San Diego : Sharp Rees-Stealy Medical Group
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
San Diego : Santarus Clinical Investigational Site 1053
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
San Diego : Santarus Clinical Investigational Site 1003
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
San Diego :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
San Francisco : University of California, San Francisco
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Colorado
Aurora : University of CO Health Sciences Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Lafayette : Gastroenterology of the Rockies
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Lakewood : Rocky Mountain Gastroenterology Associates P.L.L.C.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Littleton : Arapahoe Gastroenterology Associates P.C
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Lone Tree : South Denver Gastroenterology
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Pueblo : Lynn Institute of Pueblo
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Denver :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Lakewood : Rocky Mountain Gastroenterology
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Lakewood, : Investigational Site Number 840030
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Littleton : Investigational Site Number 840061
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Littleton : Santarus Clinical Investigational Site 1063
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Connecticut
Hamden : Gastroenterology Center of Connecticut, P.C.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Bristol : Santarus Clinical Investigational Site 1028
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Giolford : Endoscopy Center of Connecticut, LLC
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Guilford : Endoscopy Center of Connecticut, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Hamden : Endoscopy Center of Connecticut, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Hamden : Gastroenterology Center of Connecticut, PC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Hamden : Medical Research Center of Connecticut, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Hamden : Gastroenterology Center of Connecticut, PC
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Hamden : Medical Research Center of Connecticut, LLC
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Hamden : Endoscopy Center of Connecticut, LLC
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Hamden : Santarus Clinical Investigational Site 1018
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Hartford : Connecticut Children's Medical Center
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Hartford :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
New Haven :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Florida
Gainesville : University of Florida
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Jacksonville : Borland-Groover Clinic
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Jacksonville : University of Florida, Jacksonville
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Jacksonville : East Coast Institute for Research
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Melbourne : Osler Clinical Research
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Miami : University of Miami Miller School of Medicine
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
New Smyrna Beach : United Medical Research Institute
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Orlando : Internal Medicine Specialists
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Orlando : Compass Research LLC
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Palm Harbor : Advanced Gastroenterology Associates
Ulcerative Colitis
Port Orange : Accord Clinical Research, LLC
Ulcerative Colitis
Tampa : University of South Florida
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Tampa : West Wind'r Research & Development, LLC
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Winter Park : Shafran Gastroenterology Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Boynton : Santarus Clinical Investigational Site 1035
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Boynton Beach : Investigational Site Number 840054
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Clearwater : Investigational Site Number 840050
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Cooper City : South Broway Ebdiscopy
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Dundin : North Pinellas Surgery Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Gainesville :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Hialeah : Digestive Medical Associates
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Hollywood : Southern Clinical Research Consultants
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Jacksonville : Santarus Clinical Investigational Site 1045
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Largo : Santarus Clinical Investigational Site 1001
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Maitland : Center for Advanced Gastroenterology
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Maitland : MNH Surgical Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Maitland : Investigational Site Number 840041
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Maitland : Santarus Clinical Investigational Site 1024
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Miami : Jackson Memorial Hospital
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
Miami :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Miami : Research Site
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
Miramar : Santarus Clinical Investigational Site 1013
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Miramar, : Investigational Site Number 840008
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Naples : Gastroenterology Group of Naples
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Naples : Gastroenterology Group of Naples
Dose Escalation and Remission (DEAR)
Naples : Investigational Site Number 840044
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
New Smyrna Beach : Santarus Clinical Investigational Site 1009
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Orlando : Citrus Ambulatory Surgery Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Orlando : Internal Medicine Specialists
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Orlando : Santarus Clinical Investigational Site 1041
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Palm Harbor : Advanced Gastroenterology Associates, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Palm Harbor : West Coast Radiology
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Palm Harbor : Advanced Gastroenterology Associates
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Port Orange : Santarus Clinical Investigational Site 1029
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Tampa : West Wind'r Research & Development, LLC
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Winter Park : Shafran Gastroenterology Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Winter Park : Shafran Gastroenterology Center
Dose Escalation and Remission (DEAR)
Winter Park : Santarus Clinical Investigational Site 1010
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Winter Park : Shafran Gastroenterology
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Winter Park, : Investigational Site Number 840048
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Zephyrhills : Florida Medical Clinic
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Zephyrhills : Florida Medical Clinic
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Zephyrhills : Florida Medical Clinic
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Zephyrhills : Santarus Clinical Investigational Site 1002
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Georgia
Atlanta : Atlanta Gastroenterology Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Decatur : Atlanta Center for Gastroenterology, P.C.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Macon : Gastroenterology Associates of Central Georgia
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Newnan : Digestive Research Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Savannah : St. Joseph's/Candler Health System
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Snellville : DLW Research System
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Agusta : Investigational Site Number 840073
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Alpharetta : Georgia Endoscopy Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Alpharetta : Georgia Endoscopy Center
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Athens : Tri-County Research
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Atlanta : GI Consultants
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Atlanta : GI Consultants
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Atlanta : Atlanta Gastroenterology Associates
Dose Escalation and Remission (DEAR)
Atlanta :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Atlanta :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Decatur : Atlanta Center for Gastroenterology, P.C.
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Decatur : Santarus Clinical Investigational Site 1050
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Decatur : The Atlanta Center for Gastroenterology
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Johns Creek : Emory Healthcare Heart Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Johns Creek : Emory Healthcare Heart Center
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Macon : Gastroenterology Associates of Central Georgia, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Macon : Gastroenterology Associates of Central Georgia, LLC
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Marietta : Santarus Clinical Investigational Site 1085
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Suwanee : Atlanta Gastroenterology Associates
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Suwanee : Johns Creek Diagnostic Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Suwanee : Atlanta Gastroenterology Associates
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Suwanee : Johns Creek Diagnostic Center
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Idaho
Boise :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Illinois
Chicago : Rush University Medical Center - Treatment Research Center
Dysbiosis in inflammatory bowel disease.
Urbana : Carle Clinic Association P.C.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Arlington Heights : NCH Medical Group
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Chicago : Investigational Site Number 840001
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Chicago : Santarus Clinical Investigational Site 1075
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Chicago :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Oak Lawn : Southwest Gastroenterology
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Oak Lawn : Investigational Site Number 840005
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Oak Lawn : Santarus Clinical Investigational Site 1065
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Indiana
Indianapolis : Santarus Clinical Investigational Site 1058
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Iowa
Clive : Digestive & Liver Consultants
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Clive : Iowa Digestive Disease Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Clive : Santarus Clinical Investigational Site 1008
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Davenport : Gastrointestinal Clinic of Quad Cities
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Kansas
Kansas City : University Of Kansas
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Topeka : Cotton O'Neil Digestive Health Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Pratt : Santarus Clinical Investigational Site 1052
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Topeka : Cotton-O'Neil Clinical Research Center, Digestive Health
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Wichita : Professional Research Network of Kansas
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Kentucky
Lexington : University of Kentucky Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Louisville : University Of Louisville
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Louisiana
Baton Rouge : Gastroenterology Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Metairie : Santarus Clinical Investigational Site 1034
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
New Orleans :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Shreveport : Santarus Clinical Investigational Site 1032
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Maine
Portland :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Maryland
Baltimore : University of Maryland Medical Group
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Chevy Chase : Metropolitan Gastroenterology Group, P.C.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Chevy Chase : Metropolitan Gastroenterology Group, PC Chevy Chase Clinical Research
Ulcerative Colitis and Crohn’s Disease (IBD) Research Study
Prince Frederick : Shah Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Annapolis : Santarus Clinical Investigational Site 1044
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Baltimore : University of Maryland Medical Center
Dose Escalation and Remission (DEAR)
Chevy Chase : Metropolitan Gastroenterology Group, PC - Chevy Chase Clinical Research
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Chevy Chase : Chevy Chase Clinical Research
Dose Escalation and Remission (DEAR)
Chevy Chase : Santarus Clinical Investigational Site 1057
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Hollywood : Investigational Site Number 840049
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Hollywood : Santarus Clinical Investigational Site 1012
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Prince Frederick : Shah Associates, MD, LLC
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Massachusetts
Boston : Massachusetts General Hospital
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Boston : Boston Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Boston :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Worcester :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Michigan
Dearborn : The Center for Clinical Studies
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Troy : Center for Digestive Health
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Wyoming : Gastroenterology Associates of Western Michigan, P.L.C.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Ann Arbor : University of Michigan Health Systems - A. Alfred Taubman Health Care Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Ann Arbor :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Berkley : Dr. Jason Bozdin, M.D.
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Chesterfield : Clinical Research Institute of Michigan, LLC
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Chesterfield : Clinical Research Institute of Michigan, LLC
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Chesterfield : Santarus Clinical Investigational Site 1016
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Detroit :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Novi : Santarus Clinical Investigational Site 1081
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Troy : Center for Digestive Health
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Troy : Center for Digestive Health
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Utica : Utica Surgery Center (Endoscopy ONLY)
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Wyoming : Investigational Site Number 840011
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Wyoming : Santarus Clinical Investigational Site 1015
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Wyoming : Gregory Cammel, MD PLC
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Ypsilanti : Santarus Clinical Investigational Site 1068
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Minnesota
Plymouth : Minnesota Gastroenterology, P.A.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Rochester : Mayo Clinic
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Minneapolis :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Plymouth : Minnesota Gastroenterology, P.A.
Dose Escalation and Remission (DEAR)
Rochester : Mayo Clinic
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Rochester : Santarus Clinical Investigational Site 1074
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Rochester : Mayo Clinic
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Rochester :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Rochester :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Saint Paul :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Mississippi
Jackson : Santarus Clinical Investigational Site 1049
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Jackson : GI Associates and Endoscopy Center
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Ocean Springs : Investigational Site Number 840060
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Missouri
Kansas City : Truman Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Mexico : Center for Digestive and Liver Diseases, Inc.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
St. Louis : Washington University
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
St. Louis : St. Louis Center for Clinical Research
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Columbia : Surgery Center of Columbia
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Hannibal : Hannibal Regional Hospital
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Mexico : Audrain Medical Center
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Mexico : Center for Digestive & Liver Disease, Inc.
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Mexico : Investigational Site Number 840024
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Nebraska
Boys Town :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
New Hampshire
Lebanon : Dartmouth-Hitchcock Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Lebanon : Santarus Clinical Investigational Site 1061
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Manchester :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
New Jersey
Morristown : Affiliates in Gastroenterology PA
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
New Brunswick : University of Medicine and Dentistry of New Jersey-NJMS
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Vineland : The Gastroenterology Group of South Jersey
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Egg Harbour Township : AGA Clinical Research Associates, LLC
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Marlton : South Jersey Gastroenterology
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Marlton : South Jersey Gastroenterology
Dose Escalation and Remission (DEAR)
Marlton : Santarus Clinical Investigational Site 1056
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Mays Landing :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Morristown :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Vineland : The Gastroenterology Group of South Jersey
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Vineland : The Gastroenterology Group of South Jersey
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Vineland : The Gastroenterology Group of South Jersey
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
New York
Bayside : Hepatobiliary Associates of New York
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Cheektowaga : Digestive Health Physician
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Great Neck : Long Island Clinical Research Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Merrick : Long Island Gastroenterology Group, P.C.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
New York : The Rockefeller University Hospital
Inflammatory Bowel Disease Exacerbation and Changes in Gut Microbiome and Innate Immunity
New York : Present Chapman Marion Steinlauf MD PC
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
New York : New York Presbyterian Hospital
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Pittsford : Kim, Chung MD (Private Practice)
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Rochester : University of Rochester
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Setauket : Long Island Digestive Disease Consultants
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Stonybrook : SUNY Stony Brook University Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Syracuse : Syracuse Gastroenterological Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Brooklyn :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Buffalo :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Cheektowaga : Santarus Clinical Investigational Site 1021
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Great Neck : Nassau Gastroenterology Associates
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Great Neck : Long Island Clinical Research Associates, LLP
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Great Neck : Nassau Gastroenterology Associates, PC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Great Neck : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Great Neck : Investigational Site Number 840051
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Great Neck :
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Great Neck : Santarus Clinical Investigational Site 1027
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Great Neck : Santarus Clinical Investigational Site 1072
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Great Neck : Long Island Clinical Research Associates, LLP
Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis
Great Neck : Long Island Clinical Research Associates
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Great Neck :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Lake Success : Santarus Clinical Investigational Site 1067
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Mineola :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
New Hyde Park :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
New York : Santarus Clinical Investigational Site 1031
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
New York : Research Associates of New York
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
New York :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Stony Brook :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Syracuse :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
North Carolina
Chapel Hill : University of North Carolina at Chapel Hill
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Charlotte : Charlotte Gastroentology and Hepatology, P.L.L.C
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Elkin : Northwest Piedmont Clinical Research, Inc.
An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease
Elkin : Northwest Piedmont Clinical Research, Inc.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Morganton : Burke Research Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Raleigh : Multi-Specialty Research Associates of NC
Do you have ulcerative colitis in remission?
Raleigh : Wake Research Associates
Struggling with Ulcerative Colitis?
Raleigh : Wake Research Associates
Study of Mild to Moderate Ulcerative Colitis
View More »
Boone : Santarus Clinical Investigational Site 1040
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Chapel Hill :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Davidson : Carolina Digestive Health Associates
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Durham :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Greensboro : LeBauer Endoscopy Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Greensboro : LeBauer HealthCare
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Greensboro : LeBauer Research Associates, P.A.
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Greenville : Carolina Research - Carolina Digestive Diseases
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Jacksonville, : Investigational Site Number 840018
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Wilmington : Santarus Clinical Investigational Site 1073
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Ohio
Cincinnati : Consultants for Clinical Research Inc.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Dayton : Dayton Science Institute
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Cincinati : Santarus Clinical Investigational Site 1080
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Cincinnati : Endoscopy Center North
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Cincinnati : Gastroenterology Research Consultants of Greater Cincinnati
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Cincinnati : MED+ Urgent Care
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Cincinnati : Investigational Site Number 840046
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Cincinnati :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Columbus : Investigational Site Number 840006
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Dayton : Santarus Clinical Investigational Site 1082
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Mentor : Great Lakes Gastroenterology
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Mentor : Santarus Clinical Investigational Site 1017
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Oklahoma
Tulsa : Options Health Research
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Norman : Central Sooner Research
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Oklahoma City : Oklahoma Foundation for Digestive Research
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Oklahoma City :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Tulsa : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Tulsa : Gastroenterology United Tulsa
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Tulsa : Options Health Research
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Oregon
Portland : The Oregon Clinic-West Hills Gastroenterology
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Pennsylvania
Pittsburgh : University of Pittsburgh Medical Center - Cancer Centers
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Danville :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Lancaster : Regional Gastroenterology Associates of Lancaster, Ltd.
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Lancaster : Santarus Clinical Investigational Site 1064
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Philadelphia : University of Pennsylvania - Presbyterian Medical Center
Dose Escalation and Remission (DEAR)
Philadelphia : University of Pennsylvania
Study of Cimzia for the Treatment of Ulcerative Colitis
Philadelphia :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Phoenixville : Investigational Site Number 840045
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Sayre : Donald Guthrie Foundation for Education and Research
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Sayre : Investigational Site Number 840022
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
South Carolina
Charleston : Medical University Of SC CAR
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Greenville :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Tennessee
Germantown : Gastroenterology Center of the MidSouth, PC
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Nashville : Vanderbilt University Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Germantown : Memphis Gastroenterology Group
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Hermitage : Hermitage Imaging
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Hermitage : Associated Endoscopy
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Hermitage : Associates in Gastroenteroogy
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Knoxville :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Memphis :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Nashville : Inflammatory Bowel Disease Clinic c/o Divison of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, Vanderbilt University
Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use
Texas
Austin : Austin Gastroenterology, PA
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Houston : Gastroenterology Consultants
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Houston : Jacon Medical Research Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Houston : Baylor College Of Medicine
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Houston : Bayou City Research, Ltd.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Pasadena : Digestive Health Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
San Antonio : Stone Oak Research Foundation
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Tyler : Digestive Health Specialists of Tyler
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Austin : Santarus Clinical Investigational Site 1059
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Dallas : Dallas VA Medical Center
Exacerbating Factors in Inflammatory Bowel Disease
Dallas : Dallas VA Medical Center
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Dallas :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Fort Worth :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Houston : Gastroenterology Consultants, P.A.
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Houston : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Houston : Santarus Clinical Investigational Site 1019
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Houston : Santarus Clinical Investigational Site 1039
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Houston : Santarus Clinical Investigational Site 1004
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Houston : Santarus Clinical Investigational Site 1066
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Pasadena : Pasadena Gastroenterology Associates, P.A. dba Digestive Health Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Pasadena : Santarus Clinical Investigational Site 1005
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Pasadena, : Investigational Site Number 840019
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
San Antonio : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Sugar Land : Investigational Site Number 840038
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
The Woodlands : Santarus Clinical Investigational Site 1048
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Tyler : Digestive Health Specialists of Tyler
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Tyler : Digestive Health Specialists of Tyler
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Tyler : Digestive Health Specialists of Tyler
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Utah
Sandy : Granite Peaks Gastroenterology
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Lancaster : Santarus Clinical Investigational Site 1014
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Ogden : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Ogden : Santarus Clinical Investigational Site 1020
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Salt Lake City : Wasatch Clinical Research
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Salt Lake City : Wasatch Endoscopy Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Salt Lake City : Alpine Medical Group
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
West Jordan : RGL Medical Services
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Vermont
Burlington :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Virginia
Charlottesville : University of Virginia Health System
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Chesapeake : Gastroenterology Associates of Tidewater
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of XXXXXXXXX Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis.
Fairfax : Gastroenterology Associates of Northern Virginia
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Norfolk : Digestive and Liver Disease Specialist Ltd
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Richmond : Hunter Holmes McGuire VA Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Charlottesville :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Chesapeake : Santarus Clinical Investigational Site 1038
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Christianburg : Santarus Clinical Investigational Site 1025
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Fairfax :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Norfolk :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Richmond : Santarus Clinical Investigational Site 1007
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Washington
Edmonds : Puget Sound Medical Research
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Seattle : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Seattle : University of Washington
Study of Cimzia for the Treatment of Ulcerative Colitis
Seattle :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Wisconsin
Madison : Pharmaseek, LLC
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Milwaukee : Wisconsin Center for Advanced Research
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Milwaukee : Medical College Of Wisconsin
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Madison : Santarus Clinical Investigational Site 1036
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Madison :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Milwaukee : Wisconsin Center for Advanced Research - GI Associates, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Milwaukee : Center for Digestive Health
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Milwaukee : Wisconsin Center for Advanced Research
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Milwaukee :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Wauwatosa : Investigational Site Number 840064
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Australia
Adelaide : Research Site
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Adelaide : Research Site
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
Fitzroy :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Garran :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Herston : Research Site
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
View More »
Herston : Research Site
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
Nedlands : Research Site
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Parkville :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Prahran : Research Site
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Prahran : Research Site
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
Belgium
Bonheiden : Site Reference ID/Investigator# 61091
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Ghent : Site Reference ID/Investigator# 61089
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Leuven : Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Leuven : UZ Leuven
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Leuven :
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Bulgaria
Pleven : Santarus Clinical Investigational Site 4003
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Ruse : Santarus Clinical Investigational Site 4008
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Sofia :
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
Sofia : Santarus Clinical Investigational Site 4001
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Canada
Calgary : Site Reference ID/Investigator# 61408
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
London : Site Reference ID/Investigator# 61405
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
London : Santarus Clinical Investigational Site 2004
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
London : Santarus Clinical Investigational Site 2005
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
London :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
View More »
Montreal : Santarus Clinical Investigational Site 2009
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Quebec : Centre Hospitalier Universitaire de Quebec - Hotel-Dieu de Quebec
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Sherbrooke : Santarus Clinical Investigational Site 2001
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Toronto :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Vaughan : Santarus Clinical Investigational Site 2002
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Victoria : Site Reference ID/Investigator# 61409
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Winnipeg : Site Reference ID/Investigator# 61403
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Winnipeg : Santarus Clinical Investigational Site 2003
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
China
Beijing : Updated
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
Chengdu : Updated
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
Guangzhou : Updated
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
Hefei : Updated
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
Shanghai : Updated
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
View More »
Wuhan : Updated
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
Xian : Updated
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
Croatia
Zagreb :
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
Czech Republic
Hradec Kralove : Research Sites 402 and 404
A clinical research study for patients 18 or older with Ulcerative Colitis
Ostrava : Research Sites 406 and 407
A clinical research study for patients 18 or older with Ulcerative Colitis
Prague : Research Sites 405 and 409
A clinical research study for patients 18 or older with Ulcerative Colitis
Slany : Research Site 403
A clinical research study for patients 18 or older with Ulcerative Colitis
Tabor : Research Site 401
A clinical research study for patients 18 or older with Ulcerative Colitis
View More »
Ceske Budejovice : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Hradec Kralove : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Hradec Kralove : Santarus Clinical Investigational Site 3001
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Hradec Kralove : Santarus Clinical Investigational Site 3006
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Hradec Kralove :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Jablonec Nad Nisou : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Labem : Santarus Clinical Investigational Site 3005
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Nachod :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Olomouc : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Ostrava - Poruba :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Praha : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Praha : Santarus Clinical Investigational Site 3007
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Tabor : Santarus Clinical Investigational Site 3002
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Usti nad Orlici : Santarus Clinical Investigational Site 3010
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Valasske Mezirici : Santarus Clinical Investigational Site 3011
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Zlin :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Denmark
Aalborg : Site Reference ID/Investigator# 61117
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Aarhus :
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
Allerod : Noreba
Trial on Profermin and Fresubin in Ulcerative Colitis
Hvidovre : Site Reference ID/Investigator# 61119
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Odense : Odense University Hospital
Adalimumab in the Treatment of Chronic Pouchitis
View More »
Odense C : Odense University Hospital
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Estonia
Tallinn : ECG Unit, East Tallinn Central Hospital
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Tallinn : X-Ray Unit, East Tallinn Central Hospital
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Tallinn : Santarus Clinical Investigational Site 8001
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
France
Amiens : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Caen : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Clichy : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Grenoble Cedex 09 : Site Reference ID/Investigator# 61055
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Nice Cedex 3 : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
View More »
Pessac : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Rouen : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
St. Priest en Jarez : Site Reference ID/Investigator# 61063
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Vandoeuvre Les Nancy : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Vandoeuvre les Nancy Cedex : Site Reference ID/Investigator# 63462
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Germany
Berlin : Research Site 501
A clinical research study for patients 18 or older with Ulcerative Colitis
Bottrop : Research Site 508
A clinical research study for patients 18 or older with Ulcerative Colitis
Freiburg : Research Site 509
A clinical research study for patients 18 or older with Ulcerative Colitis
Hannover : Research Site 504
A clinical research study for patients 18 or older with Ulcerative Colitis
Jena : Research Site 503
A clinical research study for patients 18 or older with Ulcerative Colitis
Muenster : Research Site 506
A clinical research study for patients 18 or older with Ulcerative Colitis
Regensburg : Research Site 507
A clinical research study for patients 18 or older with Ulcerative Colitis
Stade : Research Site 502
A clinical research study for patients 18 or older with Ulcerative Colitis
Ulm : Research Site 505
A clinical research study for patients 18 or older with Ulcerative Colitis
View More »
Berlin : Site Reference ID/Investigator# 61064
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Berlin : Charité Campus Benjamin Franklin, Medizinische Klinik I
Endomicroscopy in Ulcerative Colitis
Erlangen : Department of Medicine I, University of Erlangen-Nuremberg
Endomicroscopy in IBD Patients
Hannover : Medizinishce Hochschule hannover
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Hannover :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Herne : Site Reference ID/Investigator# 61066
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Jena : Friedrich-Schiller-Universität Jena, Klinik für Innere Medizin II
Endomicroscopy in Ulcerative Colitis
Lübeck :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Ludwigshafen : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Mainz : Johannes Gutenberg-Universität Mainz, I. Med. Klinik und Poliklinik
Endomicroscopy in Ulcerative Colitis
Minden :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Muenster : Site Reference ID/Investigator# 61067
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Oelde : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Potsdam : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Ulm : Universitaetsklinikum Ulm
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
ULM :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Wangen : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Hungary
Bekescsaba : Research Site 205
A clinical research study for patients 18 or older with Ulcerative Colitis
Budapest : Research Sites 204 and 207
A clinical research study for patients 18 or older with Ulcerative Colitis
Kaposvar : Research Site 203
A clinical research study for patients 18 or older with Ulcerative Colitis
Szekszard : Research Site 202
A clinical research study for patients 18 or older with Ulcerative Colitis
View More »
Budapest :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Debrecen : Santarus Clinical Investigational Site 5001
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
GYR :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Gyula :
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
Gyula : Santarus Clinical Investigational Site 5003
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Kaposvar : Santarus Clinical Investigational Site 5004
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Mosonmagyarovar : Santarus Clinical Investigational Site 5006
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Pecs : Santarus Clinical Investigational Site 5011
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Szeged : Santarus Clinical Investigational Site 5005
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Vac : Santarus Clinical Investigational Site 5007
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Ireland
Dublin 9 : Site Reference ID/Investigator# 65989
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Israel
Haifa : Rambam Medical Center
Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis
Haifa :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Jerusalem : Shaare Zedek Medical center
Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis
Jerusalem : Hadassah medical center
Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis
Jerusalem :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
View More »
Ramat-gan :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Tel Aviv : Sourasky Medical Center
Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis
Tel Aviv :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Italy
Bologna : Research Site 301
A clinical research study for patients 18 or older with Ulcerative Colitis
Rome : Research Sites 302 and 304
A clinical research study for patients 18 or older with Ulcerative Colitis
Torino : Research Site 303
A clinical research study for patients 18 or older with Ulcerative Colitis
View More »
Crema : Ospedale Maggiore di Crema, Endoscopy and Gastroenterology Division
Endomicroscopy in Ulcerative Colitis
Firenze : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Milano : European Institute of Oncology, Division of Endoscopy
Endomicroscopy in Ulcerative Colitis
Padova : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Roma : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Rome : Site Reference ID/Investigator# 61115
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Rozzano : Site Reference ID/Investigator# 61111
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Rozzano : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Japan
Chikushino : Fukuoka University Chikushi Hospital
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Hokkaido : Sapporo higashi tokushukai hospital
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Osaka : Osaka City University Hospital
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Sapporo : Hokkaido P.W.F.A.C Sapporo-Kosei general Hospital
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Sendai : National Hospital Organization Sendai Medical Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
View More »
Takatsuki-shi : Osaka Medical College Hospital
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Latvia
Riga : Santarus Clinical Investigational Site 8101
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Riga : Santarus Clinical Investigational Site 8102
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Riga : Santarus Clinical Investigational Site 8103
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Lithuania
Kaunas : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Kaunas : Santarus Clinical Investigational Site 8202
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Klaipeda : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Siauliai : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Vilnius : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
View More »
Vilnius : Santarus Clinical Investigational Site 8201
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Vilnius : Santarus Clinical Investigational Site 8203
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Netherlands
Almere : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Amersfoort : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Eindhoven : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Nieuwegein : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Rotterdam : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
New Zealand
Auckland :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Christchurch :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Tauranga : Clinical Trials Unit, BOP Clinical School, Bay of Plenty District Health Board
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Poland
Krakow : Research Site 604
A clinical research study for patients 18 or older with Ulcerative Colitis
Lodz : Research Site 605
A clinical research study for patients 18 or older with Ulcerative Colitis
Warszawa : Research Sites 601, 602, 603
A clinical research study for patients 18 or older with Ulcerative Colitis
View More »
Bydgoszcz : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Czestochowa : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Elblag : Santarus Clinical Investigational Site 6003
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Katowice :
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
Krakow : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Lodz : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Lodz : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Lublin : Klinika Pediatrii Dzieciecy Szpital Kliniczny im prof Antoniego Gebali
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Rzeszow : Kliniczny Oddzial Pediatrii z Pododdzialem Neurologii Dzieciecej Szpital Wojewodzki
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Rzgowska : Klinika Gastroenterolofii Pediatrii, Instytut Centrum Zdrowia Matki Polki
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Sopot : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Sopot : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Sopot : Santarus Clinical Investigational Site 6002
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Szczecin : Santarus Clinical Investigational Site 6006
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Warszawa : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Warszawa : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Warszawa : Santarus Clinical Investigational Site 6004
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Warszawa : Oddzial Gastroenterologii i Hepatologii, Instytut Pomnik-Centrum Zdrowia Dziecka
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Warszawy : Santarus Clinical Investigational Site 6005
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Wieliczka : Klinika Pediatrii Gastroenterologii i Zywienia, Uniwersytecki Szpital Dzieciecy w Krakowie
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Wroclaw : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Zabrze : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Puerto Rico
Ponce : Pharmaseek, LLC
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Russian Federation
Moscow :
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
Nizhny Novgorod : Santarus Clinical Investigational Site 9004
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Ryazan : Santarus Clinical Investigational Site 9003
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Saratov : Santarus Clinical Investigational Site 9009
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Stavropol : Santarus Clinical Investigational Site 9007
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
View More »
Ufa : Santarus Clinical Investigational Site 9006
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Slovakia
Banska Bystrica : DFNsP Banska Bystrica
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Limbova 2 : Gastroenterologicka ambulancia
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Martin : Univerzitna nemocnica Martin
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Nitra : Kardiocentrum Nitra s.r.o.
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Nitra : Jessenius - diagnosticke centrum a.s.
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
View More »
Nitra : KM Management spol. s r.o.
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Nitra : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Nove Mesto nad Vahom : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Sweden
Stockholm : Södersjukhuset
A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis
Stockholm : Novartis Investigator Site
Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients
Ukraine
Donetsk : Santarus Clinical Investigational Site 7002
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Kharkiv : Santarus Clinical Investigational Site 7004
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Kyiv : Santarus Clinical Investigational Site 7008
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Odessa :
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
Vinnytsia : Santarus Clinical Investigational Site 7005
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
United Kingdom
London : Research Site 102
A clinical research study for patients 18 or older with Ulcerative Colitis
Norwich : Research Site 103
A clinical research study for patients 18 or older with Ulcerative Colitis
Nottingham : Research Site 101
A clinical research study for patients 18 or older with Ulcerative Colitis
View More »
Birmingham :
A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
Cambridge : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Coventry :
A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
Coventry : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Gloucester : Site Reference ID/Investigator# 62367
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Liverpool :
A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
Liverpool : Royal Liverpool University Hospital
Rituximab in Ulcerative Colitis
Newcastle Upon Tyne :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Oxford : Site Reference ID/Investigator# 61046
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Oxford : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Reading : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Shrewsbury : Research Site
Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Southampton : Site Reference ID/Investigator# 62568
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Wigan :
A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
Worthing : Worthing Hospital
Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)
